Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical proteomics: Insights from IGF-I

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reference values for leptin/adiponectin ratio in healthy children and adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Validation of image cytometry for sperm concentration measurement: Comparison with manual counting of 4010 human semen samples

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clinical usefulness of bone turnover marker concentrations in osteoporosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Calcium transport in male reproduction is possibly influenced by vitamin D and CaSR

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Accelerated loss of oogonia and impaired folliculogenesis in females with Turner syndrome start during early fetal development

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Associations of serum phthalate metabolites with thyroid hormones in GraMo cohort, Southern Spain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Thyroid function in COVID-19 and the association with cytokine levels and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Clinical proteomics aims to deliver cost-effective multiplexing of potentially hundreds of diagnostic proteins, including distinct protein isoforms. The analytical strategy known as targeted proteomics is particularly promising because it is compatible with robust mass spectrometry (MS)-platforms already implemented in many clinical laboratories for routine quantitation of small molecules (i.e. uHPLC coupled to triple-quadrupole MS). Progress in targeted proteomics of circulating insulin-like growth factor 1 (IGF-I) have provided valuable insights about tryptic peptides, transitions, internal standards and calibrants. The present challenge is to examine if targeted proteomics of IGF-I can truly measure up to the routine performance that must be expected from a clinical testing platform.

OriginalsprogEngelsk
TidsskriftClinica chimica acta; international journal of clinical chemistry
Vol/bind477
Sider (fra-til)18-23
Antal sider6
ISSN0009-8981
DOI
StatusUdgivet - feb. 2018

ID: 52794201